Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 44 entries
Sorted by: Best Match Show Resources per page
T cell progenitor therapy-facilitated thymopoiesis depends upon thymic input and continued thymic microenvironment interaction.

JCI insight

Smith MJ, Reichenbach DK, Parker SL, Riddle MJ, Mitchell J, Osum KC, Mohtashami M, Stefanski HE, Fife BT, Bhandoola A, Hogquist KA, Holländer GA, Zúñiga-Pflücker JC, Tolar J, Blazar BR.
PMID: 28515359
JCI Insight. 2017 May 18;2(10). doi: 10.1172/jci.insight.92056. eCollection 2017 May 18.

Infusion of in vitro-derived T cell progenitor (proT) therapy with hematopoietic stem cell transplant aids the recovery of the thymus damaged by total body irradiation. To understand the interaction between proTs and the thymic microenvironment, WT mice were lethally...

Cite
Smith MJ, Reichenbach DK, Parker SL, et al. T cell progenitor therapy-facilitated thymopoiesis depends upon thymic input and continued thymic microenvironment interaction. JCI Insight. 2017;2(10)doi: 10.1172/jci.insight.92056.
Smith, M. J., Reichenbach, D. K., Parker, S. L., Riddle, M. J., Mitchell, J., Osum, K. C., Mohtashami, M., Stefanski, H. E., Fife, B. T., Bhandoola, A., Hogquist, K. A., Holländer, G. A., Zúñiga-Pflücker, J. C., Tolar, J., & Blazar, B. R. (2017). T cell progenitor therapy-facilitated thymopoiesis depends upon thymic input and continued thymic microenvironment interaction. JCI insight, 2(10), . https://doi.org/10.1172/jci.insight.92056
Smith, Michelle J, et al. "T cell progenitor therapy-facilitated thymopoiesis depends upon thymic input and continued thymic microenvironment interaction." JCI insight vol. 2,10 (2017). doi: https://doi.org/10.1172/jci.insight.92056
Smith MJ, Reichenbach DK, Parker SL, Riddle MJ, Mitchell J, Osum KC, Mohtashami M, Stefanski HE, Fife BT, Bhandoola A, Hogquist KA, Holländer GA, Zúñiga-Pflücker JC, Tolar J, Blazar BR. T cell progenitor therapy-facilitated thymopoiesis depends upon thymic input and continued thymic microenvironment interaction. JCI Insight. 2017 May 18;2(10). doi: 10.1172/jci.insight.92056. eCollection 2017 May 18. PMID: 28515359; PMCID: PMC5436538.
Copy Download .nbib Format: NLM
Inhibition of anthocyanin formation in seedlings and flowers by the enantiomers of α-aminooxy-β-phenylpropionic acid and their N-benzyloxycarbonyl derivatives.

Planta

Amrhein N, Holländer H.
PMID: 24407328
Planta. 1979 Jan;144(4):385-9. doi: 10.1007/BF00391582.

Both enantiomers of α-aminooxy-β-phenylpropionic acid (AOPP), potent inhibitors of L-phenylalanine ammonia-lyase, and their N-benzyloxycarbonyl (N-BOC) derivatives inhibit anthocyanin formation in developing flowers of Ipomoea tricolor Cav. and Catharanthus roseus Don. as well as in seedlings of Brassica oleracea var....

Cite
Amrhein N, Holländer H. Inhibition of anthocyanin formation in seedlings and flowers by the enantiomers of α-aminooxy-β-phenylpropionic acid and their N-benzyloxycarbonyl derivatives. Planta. 1979;144(4):385-9doi: 10.1007/BF00391582.
Amrhein, N., & Holländer, H. (1979). Inhibition of anthocyanin formation in seedlings and flowers by the enantiomers of α-aminooxy-β-phenylpropionic acid and their N-benzyloxycarbonyl derivatives. Planta, 144(4), 385-9. https://doi.org/10.1007/BF00391582
Amrhein, N, and Holländer, H. "Inhibition of anthocyanin formation in seedlings and flowers by the enantiomers of α-aminooxy-β-phenylpropionic acid and their N-benzyloxycarbonyl derivatives." Planta vol. 144,4 (1979): 385-9. doi: https://doi.org/10.1007/BF00391582
Amrhein N, Holländer H. Inhibition of anthocyanin formation in seedlings and flowers by the enantiomers of α-aminooxy-β-phenylpropionic acid and their N-benzyloxycarbonyl derivatives. Planta. 1979 Jan;144(4):385-9. doi: 10.1007/BF00391582. PMID: 24407328.
Copy Download .nbib Format: NLM
The physician, the patient, and cancer.

The Illinois medical journal

HOLLENDER MH.
PMID: 13232681
Ill Med J. 1955 Jan;107(1):20-3.

No abstract available.

Cite
HOLLENDER MH. The physician, the patient, and cancer. Ill Med J. 1955;107(1):20-3
HOLLENDER, M. H. (1955). The physician, the patient, and cancer. The Illinois medical journal, 107(1), 20-3.
HOLLENDER, M H. "The physician, the patient, and cancer." The Illinois medical journal vol. 107,1 (1955): 20-3.
HOLLENDER MH. The physician, the patient, and cancer. Ill Med J. 1955 Jan;107(1):20-3. PMID: 13232681.
Copy Download .nbib Format: NLM
The Site of the Inhibition of the Shikimate Pathway by Glyphosate: I. INHIBITION BY GLYPHOSATE OF PHENYLPROPANOID SYNTHESIS IN BUCKWHEAT (FAGOPYRUM ESCULENTUM MOENCH) .

Plant physiology

Holländer H, Amrhein N.
PMID: 16661534
Plant Physiol. 1980 Nov;66(5):823-9. doi: 10.1104/pp.66.5.823.

The nonselective herbicide glyphosate (n-[phosphonomethyl]glycine) inhibited the light-induced accumulation of phenylpropanoid substances (chlorogenic acid, procyanidin, rutin, anthocyanin) in etiolated buckwheat hypocotyls 90% at 1 millimolar. Structurally related compounds, such as n,n-bis[phosphonomethyl]glycine, aminomethylphosphonate, methylglycine, and iminodiacetate, had little or no...

Cite
Holländer H, Amrhein N. The Site of the Inhibition of the Shikimate Pathway by Glyphosate: I. INHIBITION BY GLYPHOSATE OF PHENYLPROPANOID SYNTHESIS IN BUCKWHEAT (FAGOPYRUM ESCULENTUM MOENCH) . Plant Physiol. 1980;66(5):823-9doi: 10.1104/pp.66.5.823.
Holländer, H., & Amrhein, N. (1980). The Site of the Inhibition of the Shikimate Pathway by Glyphosate: I. INHIBITION BY GLYPHOSATE OF PHENYLPROPANOID SYNTHESIS IN BUCKWHEAT (FAGOPYRUM ESCULENTUM MOENCH) . Plant physiology, 66(5), 823-9. https://doi.org/10.1104/pp.66.5.823
Holländer, H, and Amrhein, N. "The Site of the Inhibition of the Shikimate Pathway by Glyphosate: I. INHIBITION BY GLYPHOSATE OF PHENYLPROPANOID SYNTHESIS IN BUCKWHEAT (FAGOPYRUM ESCULENTUM MOENCH) ." Plant physiology vol. 66,5 (1980): 823-9. doi: https://doi.org/10.1104/pp.66.5.823
Holländer H, Amrhein N. The Site of the Inhibition of the Shikimate Pathway by Glyphosate: I. INHIBITION BY GLYPHOSATE OF PHENYLPROPANOID SYNTHESIS IN BUCKWHEAT (FAGOPYRUM ESCULENTUM MOENCH) . Plant Physiol. 1980 Nov;66(5):823-9. doi: 10.1104/pp.66.5.823. PMID: 16661534; PMCID: PMC440734.
Copy Download .nbib Format: NLM
Developing educators, investigators, and leaders during internal medicine residency: the area of distinction program.

Journal of graduate medical education

Kohlwes RJ, Cornett P, Dandu M, Julian K, Vidyarthi A, Minichiello T, Shunk R, Jain S, Harleman E, Ranji S, Sharpe B, O'Sullivan P, Hollander H.
PMID: 23205204
J Grad Med Educ. 2011 Dec;3(4):535-40. doi: 10.4300/JGME-D-11-00029.1.

BACKGROUND: Professional organizations have called for individualized training approaches, as well as for opportunities for resident scholarship, to ensure that internal medicine residents have sufficient knowledge and experience to make informed career choices.CONTEXT AND PURPOSE: To address these training...

Cite
Kohlwes RJ, Cornett P, Dandu M, et al. Developing educators, investigators, and leaders during internal medicine residency: the area of distinction program. J Grad Med Educ. 2011;3(4):535-40doi: 10.4300/JGME-D-11-00029.1.
Kohlwes, R. J., Cornett, P., Dandu, M., Julian, K., Vidyarthi, A., Minichiello, T., Shunk, R., Jain, S., Harleman, E., Ranji, S., Sharpe, B., O'Sullivan, P., & Hollander, H. (2011). Developing educators, investigators, and leaders during internal medicine residency: the area of distinction program. Journal of graduate medical education, 3(4), 535-40. https://doi.org/10.4300/JGME-D-11-00029.1
Kohlwes, R Jeffrey, et al. "Developing educators, investigators, and leaders during internal medicine residency: the area of distinction program." Journal of graduate medical education vol. 3,4 (2011): 535-40. doi: https://doi.org/10.4300/JGME-D-11-00029.1
Kohlwes RJ, Cornett P, Dandu M, Julian K, Vidyarthi A, Minichiello T, Shunk R, Jain S, Harleman E, Ranji S, Sharpe B, O'Sullivan P, Hollander H. Developing educators, investigators, and leaders during internal medicine residency: the area of distinction program. J Grad Med Educ. 2011 Dec;3(4):535-40. doi: 10.4300/JGME-D-11-00029.1. PMID: 23205204; PMCID: PMC3244321.
Copy Download .nbib Format: NLM
Characterization of non-stoichiometric co-sputtered Ba0.6Sr0.4(Ti (1-x)Fe(x))(1+x)O(3-δ) thin films for tunable passive microwave applications.

Analytical and bioanalytical chemistry

Stemme F, Geßwein H, Drahus MD, Holländer B, Azucena C, Binder JR, Eichel RA, Haußelt J, Bruns M.
PMID: 22012210
Anal Bioanal Chem. 2012 May;403(3):643-50. doi: 10.1007/s00216-011-5435-z. Epub 2011 Oct 20.

The fabrication of novel iron-doped barium strontium titanate thin films by means of radio frequency (RF) magnetron co-sputtering is shown. Investigations of the elemental composition and the dopant distribution in the thin films obtained by X-ray photoelectron spectroscopy, Rutherford...

Cite
Stemme F, Geßwein H, Drahus MD, et al. Characterization of non-stoichiometric co-sputtered Ba0.6Sr0.4(Ti (1-x)Fe(x))(1+x)O(3-δ) thin films for tunable passive microwave applications. Anal Bioanal Chem. 2011;403(3):643-50doi: 10.1007/s00216-011-5435-z.
Stemme, F., Geßwein, H., Drahus, M. D., Holländer, B., Azucena, C., Binder, J. R., Eichel, R. A., Haußelt, J., & Bruns, M. (2012). Characterization of non-stoichiometric co-sputtered Ba0.6Sr0.4(Ti (1-x)Fe(x))(1+x)O(3-δ) thin films for tunable passive microwave applications. Analytical and bioanalytical chemistry, 403(3), 643-50. https://doi.org/10.1007/s00216-011-5435-z
Stemme, F, et al. "Characterization of non-stoichiometric co-sputtered Ba0.6Sr0.4(Ti (1-x)Fe(x))(1+x)O(3-δ) thin films for tunable passive microwave applications." Analytical and bioanalytical chemistry vol. 403,3 (2012): 643-50. doi: https://doi.org/10.1007/s00216-011-5435-z
Stemme F, Geßwein H, Drahus MD, Holländer B, Azucena C, Binder JR, Eichel RA, Haußelt J, Bruns M. Characterization of non-stoichiometric co-sputtered Ba0.6Sr0.4(Ti (1-x)Fe(x))(1+x)O(3-δ) thin films for tunable passive microwave applications. Anal Bioanal Chem. 2012 May;403(3):643-50. doi: 10.1007/s00216-011-5435-z. Epub 2011 Oct 20. PMID: 22012210.
Copy Download .nbib Format: NLM
Evaluating and forecasting movement patterns of magnetically driven microbeads in complex geometries.

Scientific reports

Klingbeil F, Block F, Sajjad U, Holländer RB, Deshpande S, McCord J.
PMID: 32472020
Sci Rep. 2020 May 29;10(1):8761. doi: 10.1038/s41598-020-65380-8.

The manipulation of superparamagnetic microbeads for lab-on-a-chip applications relies on the steering of microbeads across an altering stray field landscape on top of soft magnetic parent structures. Using ab initio principles, we show three-dimensional simulations forecasting the controlled movement...

Cite
Klingbeil F, Block F, Sajjad U, et al. Evaluating and forecasting movement patterns of magnetically driven microbeads in complex geometries. Sci Rep. 2020;10(1):8761doi: 10.1038/s41598-020-65380-8.
Klingbeil, F., Block, F., Sajjad, U., Holländer, R. B., Deshpande, S., & McCord, J. (2020). Evaluating and forecasting movement patterns of magnetically driven microbeads in complex geometries. Scientific reports, 10(1), 8761. https://doi.org/10.1038/s41598-020-65380-8
Klingbeil, Finn, et al. "Evaluating and forecasting movement patterns of magnetically driven microbeads in complex geometries." Scientific reports vol. 10,1 (2020): 8761. doi: https://doi.org/10.1038/s41598-020-65380-8
Klingbeil F, Block F, Sajjad U, Holländer RB, Deshpande S, McCord J. Evaluating and forecasting movement patterns of magnetically driven microbeads in complex geometries. Sci Rep. 2020 May 29;10(1):8761. doi: 10.1038/s41598-020-65380-8. PMID: 32472020; PMCID: PMC7260204.
Copy Download .nbib Format: NLM
Thymus Extracellular Matrix-Derived Scaffolds Support Graft-Resident Thymopoiesis and Long-Term In Vitro Culture of Adult Thymic Epithelial Cells.

Advanced functional materials

Asnaghi MA, Barthlott T, Gullotta F, Strusi V, Amovilli A, Hafen K, Srivastava G, Oertle P, Toni R, Wendt D, Holländer GA, Martin I.
PMID: 34539304
Adv Funct Mater. 2021 May 17;31(20):2010747. doi: 10.1002/adfm.202010747. Epub 2021 Mar 12.

The thymus provides the physiological microenvironment critical for the development of T lymphocytes, the cells that orchestrate the adaptive immune system to generate an antigen-specific response. A diverse population of stroma cells provides surface-bound and soluble molecules that orchestrate...

Cite
Asnaghi MA, Barthlott T, Gullotta F, et al. Thymus Extracellular Matrix-Derived Scaffolds Support Graft-Resident Thymopoiesis and Long-Term In Vitro Culture of Adult Thymic Epithelial Cells. Adv Funct Mater. 2021;31(20):2010747doi: 10.1002/adfm.202010747.
Asnaghi, M. A., Barthlott, T., Gullotta, F., Strusi, V., Amovilli, A., Hafen, K., Srivastava, G., Oertle, P., Toni, R., Wendt, D., Holländer, G. A., & Martin, I. (2021). Thymus Extracellular Matrix-Derived Scaffolds Support Graft-Resident Thymopoiesis and Long-Term In Vitro Culture of Adult Thymic Epithelial Cells. Advanced functional materials, 31(20), 2010747. https://doi.org/10.1002/adfm.202010747
Asnaghi, M Adelaide, et al. "Thymus Extracellular Matrix-Derived Scaffolds Support Graft-Resident Thymopoiesis and Long-Term In Vitro Culture of Adult Thymic Epithelial Cells." Advanced functional materials vol. 31,20 (2021): 2010747. doi: https://doi.org/10.1002/adfm.202010747
Asnaghi MA, Barthlott T, Gullotta F, Strusi V, Amovilli A, Hafen K, Srivastava G, Oertle P, Toni R, Wendt D, Holländer GA, Martin I. Thymus Extracellular Matrix-Derived Scaffolds Support Graft-Resident Thymopoiesis and Long-Term In Vitro Culture of Adult Thymic Epithelial Cells. Adv Funct Mater. 2021 May 17;31(20):2010747. doi: 10.1002/adfm.202010747. Epub 2021 Mar 12. PMID: 34539304; PMCID: PMC8436951.
Copy Download .nbib Format: NLM
FOXN1 forms higher-order nuclear condensates displaced by mutations causing immunodeficiency.

Science advances

Rota IA, Handel AE, Maio S, Klein F, Dhalla F, Deadman ME, Cheuk S, Newman JA, Michaels YS, Zuklys S, Prevot N, Hublitz P, Charles PD, Gkazi AS, Adamopoulou E, Qasim W, Davies EG, Hanson I, Pagnamenta AT, Camps C, Dreau HM, White A, James K, Fischer R, Gileadi O, Taylor JC, Fulga T, Lagerholm BC, Anderson G, Sezgin E, Holländer GA.
PMID: 34860543
Sci Adv. 2021 Dec 03;7(49):eabj9247. doi: 10.1126/sciadv.abj9247. Epub 2021 Dec 03.

[Figure: see text].

Cite
Rota IA, Handel AE, Maio S, et al. FOXN1 forms higher-order nuclear condensates displaced by mutations causing immunodeficiency. Sci Adv. 2021;7(49):eabj9247doi: 10.1126/sciadv.abj9247.
Rota, I. A., Handel, A. E., Maio, S., Klein, F., Dhalla, F., Deadman, M. E., Cheuk, S., Newman, J. A., Michaels, Y. S., Zuklys, S., Prevot, N., Hublitz, P., Charles, P. D., Gkazi, A. S., Adamopoulou, E., Qasim, W., Davies, E. G., Hanson, I., Pagnamenta, A. T., Camps, C., Dreau, H. M., White, A., James, K., Fischer, R., Gileadi, O., Taylor, J. C., Fulga, T., Lagerholm, B. C., Anderson, G., Sezgin, E., & Holländer, G. A. (2021). FOXN1 forms higher-order nuclear condensates displaced by mutations causing immunodeficiency. Science advances, 7(49), eabj9247. https://doi.org/10.1126/sciadv.abj9247
Rota, Ioanna A, et al. "FOXN1 forms higher-order nuclear condensates displaced by mutations causing immunodeficiency." Science advances vol. 7,49 (2021): eabj9247. doi: https://doi.org/10.1126/sciadv.abj9247
Rota IA, Handel AE, Maio S, Klein F, Dhalla F, Deadman ME, Cheuk S, Newman JA, Michaels YS, Zuklys S, Prevot N, Hublitz P, Charles PD, Gkazi AS, Adamopoulou E, Qasim W, Davies EG, Hanson I, Pagnamenta AT, Camps C, Dreau HM, White A, James K, Fischer R, Gileadi O, Taylor JC, Fulga T, Lagerholm BC, Anderson G, Sezgin E, Holländer GA. FOXN1 forms higher-order nuclear condensates displaced by mutations causing immunodeficiency. Sci Adv. 2021 Dec 03;7(49):eabj9247. doi: 10.1126/sciadv.abj9247. Epub 2021 Dec 03. PMID: 34860543; PMCID: PMC8641933.
Copy Download .nbib Format: NLM
Immunotherapy for B-cell lymphoma: current status and prospective advances.

Frontiers in immunology

Hollander N.
PMID: 22566889
Front Immunol. 2012 Jan 24;3:3. doi: 10.3389/fimmu.2012.00003. eCollection 2012.

Therapy for non-Hodgkin's lymphoma has progressed significantly over the last decades. However, the majority of patients remain incurable, and novel therapies are needed. Because immunotherapy ideally offers target selectivity, an ever increasing number of immunotherapies, both passive and active,...

Cite
Hollander N. Immunotherapy for B-cell lymphoma: current status and prospective advances. Front Immunol. 2012;3:3doi: 10.3389/fimmu.2012.00003.
Hollander, N. (2012). Immunotherapy for B-cell lymphoma: current status and prospective advances. Frontiers in immunology, 33. https://doi.org/10.3389/fimmu.2012.00003
Hollander, Nurit. "Immunotherapy for B-cell lymphoma: current status and prospective advances." Frontiers in immunology vol. 3 (2012): 3. doi: https://doi.org/10.3389/fimmu.2012.00003
Hollander N. Immunotherapy for B-cell lymphoma: current status and prospective advances. Front Immunol. 2012 Jan 24;3:3. doi: 10.3389/fimmu.2012.00003. eCollection 2012. PMID: 22566889; PMCID: PMC3342070.
Copy Download .nbib Format: NLM
Minimally Invasive Cholecystectomy: Transvaginal or Transabdominal Approach-Which Technique Is Preferred by Female Hospital Employees?.

Journal of laparoendoscopic & advanced surgical techniques. Part A

Holländer S, von Heesen M, von Heesen A, Spiliotis AE, Gäbelein G, Scherber PR, Glanemann M.
PMID: 34283667
J Laparoendosc Adv Surg Tech A. 2021 Jul 19; doi: 10.1089/lap.2021.0389. Epub 2021 Jul 19.

No abstract available.

Cite
Holländer S, von Heesen M, von Heesen A, et al. Minimally Invasive Cholecystectomy: Transvaginal or Transabdominal Approach-Which Technique Is Preferred by Female Hospital Employees?. J Laparoendosc Adv Surg Tech A. 2021;doi: 10.1089/lap.2021.0389.
Holländer, S., von Heesen, M., von Heesen, A., Spiliotis, A. E., Gäbelein, G., Scherber, P. R., & Glanemann, M. (2021). Minimally Invasive Cholecystectomy: Transvaginal or Transabdominal Approach-Which Technique Is Preferred by Female Hospital Employees?. Journal of laparoendoscopic & advanced surgical techniques. Part A, . https://doi.org/10.1089/lap.2021.0389
Holländer, Sebastian, et al. "Minimally Invasive Cholecystectomy: Transvaginal or Transabdominal Approach-Which Technique Is Preferred by Female Hospital Employees?." Journal of laparoendoscopic & advanced surgical techniques. Part A vol. (2021). doi: https://doi.org/10.1089/lap.2021.0389
Holländer S, von Heesen M, von Heesen A, Spiliotis AE, Gäbelein G, Scherber PR, Glanemann M. Minimally Invasive Cholecystectomy: Transvaginal or Transabdominal Approach-Which Technique Is Preferred by Female Hospital Employees?. J Laparoendosc Adv Surg Tech A. 2021 Jul 19; doi: 10.1089/lap.2021.0389. Epub 2021 Jul 19. PMID: 34283667.
Copy Download .nbib Format: NLM
Altered N-Linked Glycosylation in Follicular Lymphoma and Chronic Lymphocytic Leukemia: Involvement in Pathogenesis and Potential Therapeutic Targeting.

Frontiers in immunology

Hollander N, Haimovich J.
PMID: 28824637
Front Immunol. 2017 Aug 02;8:912. doi: 10.3389/fimmu.2017.00912. eCollection 2017.

B-cell antigen receptor (BCR) expression is indispensable for survival of most B-cell malignancies. In follicular lymphoma (FL), N-linked glycosylation sites are introduced in the immunoglobulin (Ig) variable region genes. Oligosaccharides added to the acquired sites are unusually of the...

Cite
Hollander N, Haimovich J. Altered N-Linked Glycosylation in Follicular Lymphoma and Chronic Lymphocytic Leukemia: Involvement in Pathogenesis and Potential Therapeutic Targeting. Front Immunol. 2017;8:912doi: 10.3389/fimmu.2017.00912.
Hollander, N., & Haimovich, J. (2017). Altered N-Linked Glycosylation in Follicular Lymphoma and Chronic Lymphocytic Leukemia: Involvement in Pathogenesis and Potential Therapeutic Targeting. Frontiers in immunology, 8912. https://doi.org/10.3389/fimmu.2017.00912
Hollander, Nurit, and Haimovich, Joseph. "Altered N-Linked Glycosylation in Follicular Lymphoma and Chronic Lymphocytic Leukemia: Involvement in Pathogenesis and Potential Therapeutic Targeting." Frontiers in immunology vol. 8 (2017): 912. doi: https://doi.org/10.3389/fimmu.2017.00912
Hollander N, Haimovich J. Altered N-Linked Glycosylation in Follicular Lymphoma and Chronic Lymphocytic Leukemia: Involvement in Pathogenesis and Potential Therapeutic Targeting. Front Immunol. 2017 Aug 02;8:912. doi: 10.3389/fimmu.2017.00912. eCollection 2017. PMID: 28824637; PMCID: PMC5539419.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 44 entries